Climb Bio (CLYM) Net Shares Issued and Repurchased (2021 - 2026)
Powered by 
Analysis
Climb Bio (CLYM) Net Shares Issued and Repurchased (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 10 | Climb Bio | 1.18 Bn | 1.18 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.21 Mn |
| Dec 31, 2025 | 5.77 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Mar 31, 2024 | 6,097.00 |
| Dec 31, 2023 | 340,283.00 |
| Dec 31, 2022 | 3.15 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 2.59 Mn |